Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

EyePoint Pharmaceuticals Inc. sell StockNews.com

Start price
€8.17
21.09.24 / 50%
Target price
-
21.09.25
Performance (%)
39.63%
End price
€11.41
22.09.25
Summary
This prediction ended on 22.09.25 with a price of €11.41. The SELL prediction by StockNews_com for EyePoint Pharmaceuticals Inc. was trending in the completely wrong direction and closed with a performance of 39.63%. StockNews_com has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
EyePoint Pharmaceuticals Inc. 7.851% 7.851% 73.353%
iShares Core DAX® 0.734% 1.458% 17.980%
iShares Nasdaq 100 -2.686% -0.146% 3.810%
iShares Nikkei 225® -2.261% -2.729% 11.679%
iShares S&P 500 -1.346% 0.467% 1.970%

Comments by StockNews_com for this prediction

In the thread EyePoint Pharmaceuticals Inc. diskutieren

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for EYPT provided by MarketBeat

In the thread Trading EyePoint Pharmaceuticals Inc.
Prediction Sell
Perf. (%) 39.63%
Target price
Change
Ends at 21.09.25

Die von StockNews_com gewählte maximale Laufzeit wurde überschritten

Stopped prediction by StockNews_com for EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€3.04
04.03.23
-
04.03.24
669.74%
05.03.24